AstraZeneca will resume its COVID-19 vaccine trial in US

Drugmaker AstraZeneca will resume the trial of its experimental coronavirus vaccine in the United States, which has been on hold since September.

10/23/2020 10:50:00 PM

Drugmaker AstraZeneca will resume the trial of its experimental coronavirus vaccine in the United States, which has been on hold since September.

Drugmaker AstraZeneca will resume the trial of its experimental coronavirus vaccine in the United States, which has been on hold since September.

The trial was paused after a volunteer in Britain developed a neurological condition suffered by one of the participants in its coronavirus vaccine clinical trials around the world.Government health officials, as well as outside experts, have said the hold is an example of how the safety process is working and protecting Americans from any potentially dangerous vaccines. Regulators wanted to check to make sure any problems could not have been caused by the vaccine.

Miss USA calls historic Miss Earth 2020 win as ‘life changing’ Mysterious monolith in US desert reportedly disappears Darth Vader actor Dave Prowse dead at 85 – agent

The company has been working with Britain’s University of Oxford to develop the vaccine, one of four that started late-stage, Phase 3 trials in the US.An internal AstraZeneca safety report obtained by CNN last month showed the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on Sept. 5. The woman was enrolled in the UK arm of the trial, which is run by the University of Oxford.

The document, labeled an “initial report,” described how the study participant had trouble walking, weakness and pain in her arms, and other symptoms.The company said in the release Thursday that results from late-stage trials are expected later this year, depending on infection rates where the trials are being conducted.

Read more: CNN Philippines »

My Love From The Star

First large-scale US COVID-19 vaccine trial reaches target enrollment of 30,000 participantsModerna, the first company to start US clinical trials of a COVID-19 vaccine, finished enrolling all 30,000 of its participants.

Golf: No spectators for US Women's Open in Covid-19 safety move

Gilead’s remdesivir gets US FDA approval for use in hospitalized COVID-19 patientsThe U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc&039;s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patientsThe U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Remdesivir, given intravenously, was one of the drugs used to treat U.S. President Donald Trump during his bout with …

US records 2nd-highest single-day rise in COVID-19 infectionsBecause they are testing more. Faster than any other country.

Avigan trial in PH faces recruitment woes due to downtrend in COVID-19 casesThe clinical trial in the Philippines for anti-viral drug Avigan has hit another snag after the Department of Health reveals that hospitals are having trouble recruiting volunteer patients. Thanks to Persida It’s more of due to people realizing this pandemic is an overreaction. Don’t believe me? Read about the latest WHO infection fatality rates and just go outside and see how many people are already going out. I hope it’s not because the priority is given to the Russian and Chinese vaccines because we need all the help that we can get as early as possible.